Northlane Capital Partners (NCP) has made an investment in SAI MedPartners (SAI), a consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries.
NCP invested in partnership with the SAI management team, led by Founder and CEO Erik Nordhoy.
Headquartered in Reading, Pennsylvania, SAI provides best-in-class competitive intelligence and strategy support services to assist its clients across the product development lifecycle.
